Synergy Spine Accelerates Cervical Disc Adoption Across the U.S.
LOUISVILLE, Colo., July 21, 2026 Synergy Spine Solutions has announced a major commercial milestone for its FDA-approved Synergy DiscĀ®,...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
LOUISVILLE, Colo., July 21, 2026 Synergy Spine Solutions has announced a major commercial milestone for its FDA-approved Synergy DiscĀ®,...
Warsaw, USA, October 28, 2025 ā Zimmer Biomet Holdings, Inc. announced that the FDA has granted Breakthrough Device Designation...
